Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 411

1.

Immunosuppressive properties of mesenchymal stromal cells derived from amnion, placenta, Wharton's jelly and umbilical cord.

Manochantr S, U-pratya Y, Kheolamai P, Rojphisan S, Chayosumrit M, Tantrawatpan C, Supokawej A, Issaragrisil S.

Intern Med J. 2013 Apr;43(4):430-9. doi: 10.1111/imj.12044.

PMID:
23176558
2.

Isolation of mesenchymal stromal cells from extraembryonic tissues and their characteristics.

Veryasov VN, Savilova AM, Buyanovskaya OA, Chulkina MM, Pavlovich SV, Sukhikh GT.

Bull Exp Biol Med. 2014 May;157(1):119-24. doi: 10.1007/s10517-014-2506-0. Epub 2014 Jun 10.

PMID:
24909727
3.

Comparison of human mesenchymal stem cells isolated by explant culture method from entire umbilical cord and Wharton's jelly matrix.

Hendijani F, Sadeghi-Aliabadi H, Haghjooy Javanmard S.

Cell Tissue Bank. 2014 Dec;15(4):555-65. doi: 10.1007/s10561-014-9425-1. Epub 2014 Feb 17.

PMID:
24532125
4.

Immunomodulatory effects of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on differentiation, maturation and endocytosis of monocyte-derived dendritic cells.

Saeidi M, Masoud A, Shakiba Y, Hadjati J, Mohyeddin Bonab M, Nicknam MH, Latifpour M, Nikbin B.

Iran J Allergy Asthma Immunol. 2013 Mar;12(1):37-49. doi: 012.01/ijaai.3749.

5.

Comparison of the ultrastructural and immunophenotypic characteristics of human umbilical cord-derived mesenchymal stromal cells and in situ cells in Wharton's jelly.

Ryu YJ, Seol HS, Cho TJ, Kwon TJ, Jang SJ, Cho J.

Ultrastruct Pathol. 2013 May;37(3):196-203. doi: 10.3109/01913123.2013.772268.

PMID:
23650992
6.

Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.

Batsali AK, Pontikoglou C, Koutroulakis D, Pavlaki KI, Damianaki A, Mavroudi I, Alpantaki K, Kouvidi E, Kontakis G, Papadaki HA.

Stem Cell Res Ther. 2017 Apr 26;8(1):102. doi: 10.1186/s13287-017-0555-9.

7.

Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor.

Najar M, Raicevic G, Boufker HI, Fayyad-Kazan H, De Bruyn C, Meuleman N, Bron D, Toungouz M, Lagneaux L.

Tissue Eng Part A. 2010 Nov;16(11):3537-46. doi: 10.1089/ten.TEA.2010.0159. Epub 2010 Aug 30.

PMID:
20597819
8.

Immunomodulatory effect of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on lymphocytes.

Zhou C, Yang B, Tian Y, Jiao H, Zheng W, Wang J, Guan F.

Cell Immunol. 2011;272(1):33-8. doi: 10.1016/j.cellimm.2011.09.010. Epub 2011 Sep 29.

9.

Comparison of biological characteristics of mesenchymal stem cells derived from maternal-origin placenta and Wharton's jelly.

Chen G, Yue A, Ruan Z, Yin Y, Wang R, Ren Y, Zhu L.

Stem Cell Res Ther. 2015 Nov 25;6:228. doi: 10.1186/s13287-015-0219-6.

10.

Pluripotent gene expression in mesenchymal stem cells from human umbilical cord Wharton's jelly and their differentiation potential to neural-like cells.

Tantrawatpan C, Manochantr S, Kheolamai P, U-Pratya Y, Supokawej A, Issaragrisil S.

J Med Assoc Thai. 2013 Sep;96(9):1208-17.

PMID:
24163998
11.

Mesenchymal stem cells isolated from peripheral blood and umbilical cord Wharton's jelly.

Trivanović D, Kocić J, Mojsilović S, Krstić A, Ilić V, Djordjević IO, Santibanez JF, Jovcić G, Terzić M, Bugarski D.

Srp Arh Celok Lek. 2013 Mar-Apr;141(3-4):178-86.

12.

Human umbilical cord Wharton's Jelly-derived mesenchymal stem cells differentiation into nerve-like cells.

Ma L, Feng XY, Cui BL, Law F, Jiang XW, Yang LY, Xie QD, Huang TH.

Chin Med J (Engl). 2005 Dec 5;118(23):1987-93.

PMID:
16336835
13.

A simple and serum-free protocol for cryopreservation of human umbilical cord as source of Wharton's jelly mesenchymal stem cells.

Roy S, Arora S, Kumari P, Ta M.

Cryobiology. 2014 Jun;68(3):467-72. doi: 10.1016/j.cryobiol.2014.03.010. Epub 2014 Apr 4.

PMID:
24704519
14.

Immunosuppressive function of mesenchymal stem cells from human umbilical cord matrix in immune thrombocytopenia patients.

Ma L, Zhou Z, Zhang D, Yang S, Wang J, Xue F, Yang Y, Yang R.

Thromb Haemost. 2012 May;107(5):937-50. doi: 10.1160/TH11-08-0596. Epub 2012 Mar 8.

PMID:
22398715
15.

Comprehensive characterization of four different populations of human mesenchymal stem cells as regards their immune properties, proliferation and differentiation.

Li X, Bai J, Ji X, Li R, Xuan Y, Wang Y.

Int J Mol Med. 2014 Sep;34(3):695-704. doi: 10.3892/ijmm.2014.1821. Epub 2014 Jun 25.

16.

Enhanced neuro-therapeutic potential of Wharton's Jelly-derived mesenchymal stem cells in comparison with bone marrow mesenchymal stem cells culture.

Drela K, Lech W, Figiel-Dabrowska A, Zychowicz M, Mikula M, Sarnowska A, Domanska-Janik K.

Cytotherapy. 2016 Apr;18(4):497-509. doi: 10.1016/j.jcyt.2016.01.006.

PMID:
26971678
17.

New emerging potentials for human Wharton's jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity.

Anzalone R, Lo Iacono M, Corrao S, Magno F, Loria T, Cappello F, Zummo G, Farina F, La Rocca G.

Stem Cells Dev. 2010 Apr;19(4):423-38. doi: 10.1089/scd.2009.0299. Review.

PMID:
19958166
18.

Human Wharton's jelly mesenchymal stem cell secretome display antiproliferative effect on leukemia cell line and produce additive cytotoxic effect in combination with doxorubicin.

Hendijani F, Javanmard SH, Sadeghi-aliabadi H.

Tissue Cell. 2015 Jun;47(3):229-34. doi: 10.1016/j.tice.2015.01.005. Epub 2015 Jan 31.

PMID:
25779671
19.

Differentiation of mesenchymal stromal cells derived from umbilical cord Wharton's jelly into hepatocyte-like cells.

Zhang YN, Lie PC, Wei X.

Cytotherapy. 2009;11(5):548-58. doi: 10.1080/14653240903051533.

PMID:
19657806
20.

Mesenchymal stem cells derived from Wharton's Jelly of the umbilical cord: biological properties and emerging clinical applications.

Batsali AK, Kastrinaki MC, Papadaki HA, Pontikoglou C.

Curr Stem Cell Res Ther. 2013 Mar;8(2):144-55. Review.

PMID:
23279098

Supplemental Content

Support Center